Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Biotech

Biotech

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Biotech
  • General
  • Global
  • Markets
  • Mid Cap
  • News
  • Penny Stocks
  • Small Cap
  • Top Stories
  • Trading Ideas

After Bill Gates Dumps Billions In Berkshire To Buy Microsoft, His Quiet Biotech Portfolio Has Made A New Trade

By Robert Kuczmarski
Today, 2:03 PM
Bill Gates has two portfolios he makes trades from: the Bill & Melinda Gates Foundation and the Bill & Melinda Gates Foundation Trust.

BCEL

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • Initiation
  • News
  • Price Target
  • Small Cap

HC Wainwright Creates Bullish Pitch On 4D Molecular Citing ‘Broader Systemic Potential’

By Vandana Singh
Today, 1:18 PM
HC Wainwright has initiated coverage on 4D Molecular Therapeutics Inc (NASDAQ:FDMT) with a price target of $36 and a Buy rating. The…

FDMT

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News
  • Small Cap

Canada Approves Novavax’s COVID-19 Vaccine As Booster In Adults

By Vandana Singh
Today, 12:32 PM
Health Canada has granted expanded approval to Novavax Inc's (NASDAQ: NVAX) Nuvaxovid (COVID-19 Vaccine as a homologous booster in adults aged 18 and older.

NVAX

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Movers
  • News
  • Trading Ideas

Apellis Pharma Shares Jump As FDA Accepts Its Lead Product Application For Eye Disease

By Vandana Singh
Today, 12:12 PM
The FDA has accepted for review Apellis Pharmaceuticals Inc’s (NASDAQ:APLS) unsolicited major amendment to the New Drug Application (NDA) for intravitreal…

APLS

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Movers
  • News
  • Small Cap
  • Trading Ideas

Iovance Biotherapeutics Pushes FDA Rolling Submission Deadline Into Next Year For Its Lead Skin Cancer Candidate

By Vandana Singh
Today, 12:09 PM
Iovance Biotherapeutics Inc (NASDAQ:IOVA) announced that its ongoing rolling Biologics License Application (BLA) submission to the FDA for lifileucel…

IOVA

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

Pfizer/BioNTech’s Omicron Tailored COVID-19 Vaccine Shows Improved Immune Response Against Emerging Omicron Sublineages

By Vandana Singh
Today, 12:03 PM
Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) announced results from an analysis examining the immune response induced by their Omicron BA.4/BA.5-tailored bivalent COVID-19…

BNTX

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Small Cap
  • Trading Ideas

Within A Month After Pulling Plug On COVID-19 Booster Study, Inovio Shelves Two More Infectious Disease Programs

By Vandana Singh
Today, 11:42 AM
Inovio Pharmaceuticals Inc (NASDAQ:INO) has agreed with its collaborator, the Coalition for Epidemic Preparedness Innovations (CEPI), to discontinue the development of…

INO

Read More
1 minute read
  • Biotech
  • General
  • News

Calyxt Achieves Phase 1 Milestone In Collaboration Agreement To Develop Alternative To Palm Oil

By Benzinga Newsdesk
Today, 11:01 AM
Calyxt, Inc. (NASDAQ:CLXT), a plant-based synthetic biology company announced today that it has successfully completed the first phase in its research collaboration agreement with a leading global food ingredient

CLXT

Read More
3 minute read
  • Biotech
  • General
  • News

Neovasc Comments On European Heart Journal Publication

By Benzinga Newsdesk
Today, 9:10 AM
 Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced that European Heart Journal - Case Reports has published an article titled, "Implantation of the

NVCN

Read More
5 minute read
  • Biotech
  • Commodities
  • FDA
  • General
  • Health Care
  • Large Cap
  • M&A
  • Markets
  • Media
  • Movers
  • News
  • Small Cap
  • Tech
  • Top Stories
  • Trading Ideas

Three Months Wait Time For Twitter Blue Mark Verification, Zuckerberg’s WhatsApp And Metaverse Plans, China’s COVID-19 Measures Hurt Alibaba’s Biggest Event: Top Stories Friday, Nov. 18

By Vandana Singh
Today, 8:59 AM
Reuters

AAPL

Posts pagination

Previous 1 … 623 624 625 … 795 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service